IMMUNITY PHARMA

immunity-pharma-logo

Immunity Pharma specializes in developing therapies for neurodegenerative diseases. Its initial is focus on Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

#SimilarOrganizations #People #Website #More

IMMUNITY PHARMA

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2007-01-01

Address:
Jerusalem, Yerushalayim, Israel

Country:
Israel

Website Url:
http://www.immunitypharma.com

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Universal Analytics Font Awesome Apache ReCAPTCHA DigiCert SSL


Similar Organizations

artham-therapeutics-logo

ARTham Therapeutics

ARTham Therapeutics is a biopharmaceutical company that delivers drugs to help patients.

b-smart-logo

B-SMART

B-SMART is an RNA-based therapy perspective for neurodegenerative diseases.

biocortex-logo

BioCorteX

BioCorteX is a pharmaceutical company specializing in enhanced therapeutics to cure neurodegenerative diseases using microorganisms.

fujirebio-logo

Fujirebio

Fujirebio provides clinical test drugs for infectious diseases, tumors, and lifestyle-related diseases.

galenea-logo

Galenea

Galenea is engaged in developing therapeutics for central nervous system diseases.

immunitor-logo

Immunitor

Immunitor develops orally-delivered immunotherapies for a number of serious diseases affecting the world.

not_available_image

MAGiQ Therapeutics

MAGiQ Therapeutics focuses on the development and licensing of regenerative medicine products generated from iPS cells.

nal-pharma-logo

NAL Pharma

NAL Pharma is a specialty drug developer that develops novel dosage forms.

neuromagen-pharma-logo

Neuromagen Pharma

Neuromagen Pharma develops drugs for neurodegenerative diseases including ALS.

not_available_image

ParaPRO

ParaPRO specializes in developing therapies for parasite infestations that afflict millions of people every year.

saliai-logo

SALIAI

SALIAI is a developer of the stem cell and regenerative medicine solution provider.

takeda-cambridge-logo

Takeda Cambridge

Takeda Cambridge specializes in developing oral diabetes medications.

tavec-pharma-logo

Tavec pharma

Tavec Pharmaceuticals is developing injectable therapies to treat cancers.

not_available_image

YAbA

YAbA has specializes in developing diagnostic tests for veternizary diseases.

Current Employees Featured

eran-ovadia_image

Eran Ovadia
Eran Ovadia CEO @ Immunity Pharma
CEO
2007-01-01

Founder


eran-ovadia_image

Eran Ovadia

Official Site Inspections

http://www.immunitypharma.com Semrush global rank: 6.14 M Semrush visits lastest month: 1.32 K

  • Host name: dedi3509.your-server.de
  • IP address: 78.46.191.201
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "Immunity Pharma"

Board of Directors - Immunity Pharma

Oren M. Becker, Ph.D. Dr. Becker is a co-Founder and member of the Board of Directors of Immunity Pharma. He brings more than 20 years of biopharmaceutical industry and leadership …See details»

About IPL - Immunity Pharma

About IPL. Immunity Pharma Ltd. (IPL) is a clinical stage biopharma company that develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS).See details»

Immunity Pharma Company Profile | Management and Employees …

Www.immunitypharma.com Immunity Pharma Profile and History Immunity Pharma Ltd. (IPL) is a privately-held clinical-stage neurology-focused biopharmaceutical company that develops …See details»

Immunity Pharma - Crunchbase Company Profile & Funding

Www.immunitypharma.com ; 439,118; Highlights. Employee Profiles 1. Similar Companies 29. Recent News & Activity. There is no recent news or activity for this profile. ... Sub-Organization …See details»

Immunity Pharma Ltd. - Drug pipelines, Patents, Clinical trials

Www.immunitypharma.com. Private Company | 2007 | Israel | www.immunitypharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & …See details»

Immunity Pharma Company Profile 2024: Valuation, Funding

Mar 8, 2022 Information on valuation, funding, cap tables, investors, and executives for Immunity Pharma. Use the PitchBook Platform to explore the full profile.See details»

Immunity Pharma Ltd. | Mevaseret Zion, Israel Startup

Website immunitypharma.com; Company Summary We develop innovative drugs that stimulate pro-survival cell-signaling processes for the treatment of neuro-degenerative diseases. Our …See details»

IMMUNITY - PHARMA LTD Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for IMMUNITY - PHARMA LTD of MEVASSERET ZION, Jerusalem Area. Get the latest business insights from …See details»

Immunity Pharma - Overview, News & Similar companies - ZoomInfo

Jan 16, 2024 Immunity Pharma Announces Positive Top Line Results from Phase 2a Trial with IPL344 in ALS Patients Treatment with IPL344 was well tolerated Changes in the slope of …See details»

Management Team - Immunity Pharma

Immunity Pharma is a drug development company that uses novel immune-based approaches to develop therapies for neuro-degenerative and inflammatory diseases.See details»

Immunity Pharma Announces Promising Interim Results

JERUSALEM, Sept. 14, 2020 /PRNewswire/ -- Immunity Pharma, a clinical-stage neurology-focused biopharmaceutical company, announced today interim results from its Phase 1/2a …See details»

Immunity Pharma Announces Positive Top Line Results from Phase …

Jan 17, 2024 /PRNewswire/ -- Immunity Pharma, a clinical-stage neurology-focused biopharmaceutical company, today announced positive top line results from the Phase 2a...See details»

Immunity Pharma gears up for pivotal trial with ALS drug

Jan 18, 2024 Immunity Pharma CEO, Eran Ovadia, said that the Phase IIa data gives the company confidence to progress the candidate to Phase III. The trial demonstrated that once …See details»

Contact - Immunity Pharma

Immunity Pharma is a drug development company that uses novel immune-based approaches to develop therapies for neuro-degenerative and inflammatory diseases.See details»

Immunity Pharma Announces Promising Interim Results of its …

JERUSALEM, Sept. 14, 2020 /PRNewswire/ -- Immunity Pharma, a clinical-stage neurology-focused biopharmaceutical company, announced today interim results from its Phase 1/2a …See details»

International Immunopharmacology | Journal - ScienceDirect

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, …See details»

News - Immunity Pharma

Jan 16, 2024 For more information, please visit www.immunitypharma.com. Neurofilament (NfL) Reduction Following IPL344 Treatment of ALS Patients . Jerusalem, Israel, December 10, …See details»

CIPO unveils our new name and brand, ImmUnity Canada

Oct 2, 2022 As we celebrate our 25th anniversary, we are thrilled to announce that the Canadian Immunodeficiencies Patient Organization (CIPO) is rebranding to ImmUnity Canada. What to …See details»

Press Releases - Immunity Pharma

Jerusalem, Israel, December 10, 2023 Indication of neurodegeneration slow down following IPL344 treatment; Immunity Pharma, a clinical-stage neurology-focusedSee details»

linkstock.net © 2022. All rights reserved